Prosecution Insights
Last updated: October 02, 2026

Xygenyx Inc.

Technology area: Biotechnology & Pharmaceuticals

15 pending office actions • 9 art units • 13 examiners • 0 of 15 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Xygenyx Inc. demonstrates a broad prosecution presence in the Biotechnology & Pharmaceuticals technology area. The company currently faces 14 pending office actions, which are distributed among 13 distinct examiners. This high number of examiners relative to the total actions suggests a wide engagement with various personnel at the USPTO. The portfolio's activity spans 9 distinct art units, indicating that the company's innovations cover a range of technical classifications within the life sciences.

BRADLEY, CHRISTINA is the busiest examiner for Xygenyx Inc., with 2 busiest examiner pending office actions under her review. While she is the most active, her 2 pending actions are a subset of the 14 total pending office actions. The fact that 13 distinct examiners are involved across 9 distinct art units highlights the complexity of managing this portfolio. Practitioners must be prepared for a variety of examination styles and technical requirements given the breadth of the current pending workload.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

15
Total Pending OAs
7
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
4
Due this month
2
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (4)Due ≤ 60 days (2)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (40%)
9
Medium (60%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (20%)
§103 only8 (53%)
Double-patenting + other1 (7%)
Multi-statute (no §101)3 (20%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

15
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

150 h
Manual time on pending OAs
30 h
Time saved (low, 20%)
52 h
Time saved (mid, 35%)
1.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ALAM, AYAAN A 2 38.4% +35.6%
BRADLEY, CHRISTINA 2 62.6% +33.3%
NEAGU, IRINA 1 46.8% +57.3%
TIEN, LUCY MINYU 1 59.3% +39.2%
RAO, PADMAJA S 1 70.7% +36.8%
DEKARSKE, MADELINE MCGUIRE 1 0.0% +0.0%
LAZARO, DOMINIC 1 63.6% +31.5%
BENAVIDES, JENNIFER ANN 1 51.2% +47.0%
BUNNER, BRIDGET E 1 64.5% +19.9%
VARADARAJ, ARCHANA 1 80.0% +33.3%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18299620 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION VARADARAJ, ARCHANA 26d

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18116849 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION BRADLEY, CHRISTINA 296d overdue
18299480 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BUNNER, BRIDGET E 21d
18299453 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BENAVIDES, JENNIFER ANN 26d
18295181 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION PARK, HAEJIN S 34d
18329491 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION RAO, PADMAJA S 40d
18329539 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION DEKARSKE, MADELINE MCGUIRE —
18118120 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION BRADLEY, CHRISTINA —

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18116849 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION BRADLEY, CHRISTINA 296d overdue
18297841 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION ALAM, AYAAN A 14d
18299480 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BUNNER, BRIDGET E 21d
18299453 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BENAVIDES, JENNIFER ANN 26d
18299620 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION VARADARAJ, ARCHANA 26d
18329491 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION RAO, PADMAJA S 40d
18329496 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION TIEN, LUCY MINYU 70d
18299716 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION LAZARO, DOMINIC 84d

Top Art Units

Art UnitApps
1611 4
1675 2
1614 2
1654 2
1629 1
1612 1
1627 1
1647 1
1658 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18338304 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION NEAGU, IRINA 1629 §103 Final Rejection — Pending Jun 20, 2023
18329496 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION TIEN, LUCY MINYU 1612 §103 Non-Final OA 70d Pending Jun 05, 2023
18329491 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION RAO, PADMAJA S 1627 §101§103 Final Rejection 40d Pending Jun 05, 2023
18329539 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY - ENHANCED SUPPLEMENTATION DEKARSKE, MADELINE MCGUIRE 1675 §103§112DP Non-Final OA — Pending Jun 05, 2023
18299716 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION LAZARO, DOMINIC 1611 §103 Final Rejection 84d Pending Apr 13, 2023
18299453 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BENAVIDES, JENNIFER ANN 1675 §102§103§112 Final Rejection 26d Pending Apr 12, 2023
18299480 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION BUNNER, BRIDGET E 1647 §103§112 Final Rejection 21d Pending Apr 12, 2023
18299620 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION VARADARAJ, ARCHANA 1658 §103 Non-Final OA 26d Pending Apr 12, 2023
18299484 COMPOSITION AND METHODS OF TREATMENT USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION ALAM, AYAAN A 1611 §103 Final Rejection — Pending Apr 12, 2023
18297841 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION ALAM, AYAAN A 1611 §103 Non-Final OA 14d Pending Apr 10, 2023
18297535 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION KETCHAM, KAREN A 1614 §103 Final Rejection 70d Pending Apr 07, 2023
18295181 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION PARK, HAEJIN S 1614 §103§112 Non-Final OA 34d Pending Apr 03, 2023
18295188 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION GHALI, ISIS A D 1611 §103 Non-Final OA — Pending Apr 03, 2023
18118120 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION BRADLEY, CHRISTINA 1654 §101§103 Final Rejection — Pending Mar 06, 2023
18116849 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL HORMONE SUPPLEMENTATION BRADLEY, CHRISTINA 1654 §101§103§112 Non-Final OA 296d overdue Pending Mar 03, 2023

Managing Xygenyx Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month